Sarah‐Jane Dawson
- Cancer Research top 0.1%
- Oncology top 0.5%
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 0.5%
- Pathology and Forensic Medicine top 0.5%
- Co-authors
- Carlos CaldasNitzan RosenfeldDana W.Y. TsuiDavina GaleTim ForshewMuhammed MurtazaSuet‐Feung ChinSean Humphray
- Topics
- Cancer Genomics and Diagnostics (41 papers)Cancer Cells and Metastasis (11 papers)Lung Cancer Treatments and Mutations (11 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Sarah‐Jane Dawson
78 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 4.7k
- Oncology 3.3k
- Molecular Biology 2.8k
- Pulmonary and Respiratory Medicine 2.3k
- Pathology and Forensic Medicine 1.5k
Countries citing papers authored by Sarah‐Jane Dawson
This map shows the geographic impact of Sarah‐Jane Dawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah‐Jane Dawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah‐Jane Dawson more than expected).
Fields of papers citing papers by Sarah‐Jane Dawson
This network shows the impact of papers produced by Sarah‐Jane Dawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah‐Jane Dawson. The network helps show where Sarah‐Jane Dawson may publish in the future.
Co-authorship network of co-authors of Sarah‐Jane Dawson
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah‐Jane Dawson. A scholar is included among the top collaborators of Sarah‐Jane Dawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah‐Jane Dawson. Sarah‐Jane Dawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 35 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 38 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 62 | |
| 9 | Non-genetic mechanisms of therapeutic resistance in cancerbreakdown → | 353 |
| 10 | 25 | |
| 11 | 8 | |
| 12 | 3 | |
| 13 | 83 | |
| 14 | The combination of ibrutinib and venetoclax (ABT-199) rapidly achieves complete remissions in patients with relapsed/refractory mantle cell lymphoma: Preliminary results of the phase II AIM study | 3 |
| 15 | 9 | |
| 16 | 207 | |
| 17 | 89 | |
| 18 | 257 | |
| 19 | 5 | |
| 20 | ALLELE SPECIFIC DIFFERENTIAL BINDING OF HEPG2 NUCLEAR EXTRACTS TO A COMMON POLYMORPHISM IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) PROMOTER WHICH IS ASSOCIATED WITH ALTERED PLASMA PAI-1 LEVELS | 2 |
About Sarah‐Jane Dawson
Sarah‐Jane Dawson is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 80 papers that have together received 7.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (41 papers), Cancer Cells and Metastasis (11 papers) and Lung Cancer Treatments and Mutations (11 papers). The work is most often cited by research in Cancer Research (4.7k citations), Oncology (3.3k citations) and Pathology and Forensic Medicine (1.5k citations). Sarah‐Jane Dawson has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Carlos Caldas, Nitzan Rosenfeld, Dana W.Y. Tsui, Davina Gale, Tim Forshew, Muhammed Murtaza, Suet‐Feung Chin, Sean Humphray, David Bentley and Mark A. Dawson. Their work appears in journals such as Nature, New England Journal of Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.